Billev farmacija vzhod, d. o. o.
Billev Pharma East Ltd.
Tržaška cesta 202
1000 Ljubljana
Slovenia
Product information is regulated and scientifically validated to aid healthcare professionals in prescribing and dispensing and to inform patients about safe use. The development of electronic product information (ePI) aims to improve access to current product information when needed.
ePI is authorized, statutory product information for EU medicines in a semi-structured electronic format using the EU Common Standard. This standard, developed by the European Medicines Agency (EMA), national competent authorities (NCAs), and the European Commission (EC), ensures consistency and reliability.
The EU ePI Common Standard is based on Fast Healthcare Interoperability Resources (FHIR), supporting the exchange of information about medicinal products and related data within the European medicines regulatory network.
Our representative, Katja Pečjak, was invited as a Subject Matter Expert (SME) to the ePI pilot project team, highlighting our commitment to advancing ePI initiatives. Alongside our partners, we offer comprehensive services related to data and document management, ensuring your pharmaceutical information is accurate, accessible, and up-to-date.
With a focus on expert guidance and strategic insights, we propel your projects forward with confidence, ensuring every step is handled with precision.
Billev farmacija vzhod, d. o. o.
Billev Pharma East Ltd.
Tržaška cesta 202
1000 Ljubljana
Slovenia
Operation title: BILLEV FARMACIJA VZHOD digitalizacija
Link to the European Cohesion Policy website: www.eu-skladi.si
“The investment is co-funded by the Republic of Slovenia and the European Union from the European Regional Development Fund”.
Regulatory Affairs
Pharmacovigilance
Medical Consultancy
Quality/GxP
Digital Consultancy